Price
Financials
Consolidated, Rs crore| Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2024 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.24 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
| Expenses | 0.76 | 0.32 | 0.35 | 0.23 | 0.07 | 0.08 | 0.06 | 0.00 | 4.93 | 3.36 | 0.17 | 0.31 |
| Operating Profit | -0.52 | -0.31 | -0.35 | -0.23 | -0.07 | -0.08 | -0.06 | 0.00 | -4.93 | -3.36 | -0.15 | -0.31 |
| OPM % | -216.67% | -3,100.00% | -750.00% | |||||||||
| Other Income | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.48 | -0.27 | -0.31 | -0.19 | -0.03 | -0.04 | -0.02 | 0.00 | -4.93 | -3.36 | -0.12 | -0.31 |
| Tax % | -14.58% | 0.00% | -3.23% | 0.00% | -66.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -0.41 | -0.27 | -0.30 | -0.19 | -0.01 | -0.04 | -0.02 | 0.00 | -4.55 | -2.94 | -0.48 | -0.19 |
| EPS in Rs | -0.28 | -0.18 | -0.20 | -0.13 | -0.01 | -0.03 | -0.01 | 0.00 | -2.00 | -1.29 | -0.21 | -0.08 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.28 | 0.58 | 1.90 | 1.43 | 0.01 | 0.02 | 0.02 | 0.00 | 0.00 | 0.02 | 0.02 |
| Expenses | 1.86 | 1.71 | 4.34 | 3.62 | 0.92 | 0.43 | 1.01 | 0.25 | 0.26 | 8.73 | 8.77 |
| Operating Profit | -0.58 | -1.13 | -2.44 | -2.19 | -0.91 | -0.41 | -0.99 | -0.25 | -0.26 | -8.71 | -8.75 |
| OPM % | -45.31% | -194.83% | -128.42% | -153.15% | -9,100.00% | -2,050.00% | -4,950.00% | -43,550.00% | -43,750.00% | ||
| Other Income | 0.01 | 0.03 | 0.11 | 0.16 | 0.15 | 1.91 | 0.29 | 0.00 | 0.00 | 0.03 | 0.03 |
| Interest | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.58 | -1.11 | -2.36 | -2.06 | -0.77 | 1.49 | -0.70 | -0.25 | -0.26 | -8.68 | -8.72 |
| Tax % | 124.14% | -5.41% | -1.27% | -3.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -1.31 | -1.05 | -2.33 | -1.98 | -0.77 | 1.49 | -0.71 | -0.26 | -0.28 | -8.16 | -8.16 |
| EPS in Rs | -1.28 | -0.89 | -1.69 | -1.34 | -0.52 | 1.01 | -0.48 | -0.18 | -0.19 | -3.59 | -3.58 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 15% | 0% | % | ||
| Compounded Profit Growth | % | % | % | -2814% | ||
| Stock Price CAGR | 4% | -22% | -10% | -38% | ||
| Return on Equity | -13% | -13% | -24% | -69% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.26 | 11.76 | 13.81 | 14.81 | 14.81 | 14.81 | 14.81 | 14.81 | 14.81 | 22.75 |
| Reserves | -2.39 | -0.40 | -1.61 | -3.03 | -3.66 | -1.58 | -2.29 | -2.55 | -2.84 | -11.00 |
| Borrowings | 6.50 | 6.81 | 7.92 | 8.58 | 2.34 | 2.74 | 2.08 | 2.20 | 2.43 | 1.66 |
| Other Liabilities | 4.88 | 4.73 | 6.11 | 7.85 | 3.09 | 1.16 | 0.96 | 1.09 | 1.17 | 0.98 |
| Total Liabilities | 19.25 | 22.90 | 26.23 | 28.21 | 16.58 | 17.13 | 15.56 | 15.55 | 15.57 | 14.39 |
| Fixed Assets | 0.46 | 0.36 | 0.26 | 0.13 | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| CWIP | 14.85 | 16.13 | 17.77 | 18.99 | 3.26 | 3.26 | 3.26 | 3.26 | 3.26 | 2.00 |
| Investments | 0.01 | 0.01 | 0.01 | 0.01 | 4.22 | 4.80 | 4.80 | 4.79 | 4.76 | 9.84 |
| Other Assets | 3.93 | 6.40 | 8.19 | 9.08 | 9.08 | 9.06 | 7.49 | 7.49 | 7.55 | 2.55 |
| Total Assets | 19.25 | 22.90 | 26.23 | 28.21 | 16.58 | 17.13 | 15.56 | 15.55 | 15.57 | 14.39 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -0.26 | -3.32 | -2.96 | -1.05 | -0.34 | -0.40 | 0.66 | -0.13 | -0.23 | -4.26 |
| Cash from Investing Activity | -1.09 | -1.19 | -1.55 | -1.11 | -0.23 | 0.00 | 0.00 | 0.00 | 0.00 | 3.26 |
| Cash from Financing Activity | 1.27 | 4.83 | 4.19 | 2.17 | 0.55 | 0.40 | -0.67 | 0.13 | 0.22 | 2.63 |
| Net Cash Flow | -0.08 | 0.32 | -0.32 | 0.01 | -0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 1.63 |
| Free Cash Flow | -0.26 | -4.51 | -4.51 | -2.16 | -0.57 | -0.40 | 0.66 | -0.13 | -0.23 | -1.00 |
| CFO/OP | 45% | 294% | 121% | 48% | 37% | 98% | -67% | 52% | 88% | 49% |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 932.46 | 1,806.12 | 424.55 | 556.43 | 78,110.00 | 38,690.00 | 38,325.00 | 365.00 | ||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Days Payable | ||||||||||
| Cash Conversion Cycle | 932.46 | 1,806.12 | 424.55 | 556.43 | 78,110.00 | 38,690.00 | 38,325.00 | 365.00 | ||
| Working Capital Days | -1,114.96 | -2,259.22 | -787.63 | -1,462.55 | 60,590.00 | 58,765.00 | 46,172.50 | -29,747.50 | ||
| ROCE % | -5.44% | -10.11% | -8.45% | -4.07% | 10.12% | -4.58% | -1.72% | -1.80% | -62.42% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 52.87% | 52.87% | 52.87% | 52.87% | 52.87% | 52.87% | 49.27% | 48.25% | 31.41% | 25.44% | 25.44% | 25.44% |
| Public | 47.12% | 47.13% | 47.13% | 47.12% | 47.13% | 47.14% | 50.72% | 51.74% | 68.58% | 74.56% | 74.57% | 74.56% |
| No. of Shareholders | 1,587 | 1,760 | 2,115 | 2,201 | 2,740 | 2,578 | 2,608 | 2,478 | 2,441 | 2,436 | 2,441 | 2,506 |
Fundamentals
Market Cap₹ 26.8 Cr.
Current Price₹ 11.8
Book Value₹ 5.16
ROCE-62.4 %
ROE-68.8 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)%
Compounded Profit Growth (TTM)-2814%
Consolidated figures.
Valuation
Market capRs 27 Cr
Enterprise valueRs 27 Cr
Price to book2.28x
Price to sales1337.68x
EV / sales1339.18x
Earnings yield-30.50%
P/B, 3-year average2.20x
P/E, 5-year average28.33x
P/B, 5-year average2.49x
Profitability
Operating margin (excl. other income)-43550.00%
Operating margin (incl. other income)-43400.00%
EBITDA margin-43600.00%
Pre-tax margin-43600.00%
Net profit margin-40800.00%
ROE-68.80%
ROCE-62.42%
ROA-54.47%
ROE, 3-year average-24.40%
ROCE, 3-year average-21.98%
ROA, 3-year average-19.31%
ROE, 5-year average-13.30%
ROCE, 5-year average-12.08%
ROA, 5-year average-10.69%
ROIC (approx.)-74.02%
Other income / net worth0.26%
Growth
Sales CAGR, 3 years0.00%
Sales CAGR, 5 years14.87%
Per share
EPS (TTM)Rs -3.59
EPS (latest year)Rs -3.59
EPS (latest quarter)Rs -0.08
EPS, 3-year averageRs -1.32
EPS, 5-year averageRs -0.69
Book value per shareRs 5.16
Sales per shareRs 0.01
Cash flow per shareRs -1.87
Free cash flow per shareRs -0.44
Efficiency
Asset turnover0.00x
Debtor days365 days
Debtors turnover1.00x
Cash conversion cycle365 days
Working capital days-29748 days
Leverage
Total debtRs 2 Cr
Cash and bankRs 2 Cr
Net debtRs 0 Cr
Debt to equity0.14x
Owners' fund to total sources81.65%
Debt to assets11.54%
Cash flow
Cash from Operating Activity (latest year)Rs -4 Cr
Cash from Investing Activity (latest year)Rs 3 Cr
Cash from Financing Activity (latest year)Rs 3 Cr
Net Cash Flow (latest year)Rs 2 Cr
Free cash flow (latest year)Rs -1 Cr
FCFE (approx.: FCF + change in debt)Rs -2 Cr
Statement figures
Net sales (TTM)Rs 0 Cr
Net sales (latest year)Rs 0 Cr
Operating profit excl. other income (latest year)Rs -9 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -9 Cr
PBDT (TTM)Rs -9 Cr
Profit before tax (TTM)Rs -9 Cr
Net profit (TTM)Rs -8 Cr
Net profit (latest year)Rs -8 Cr
Net profit (latest quarter)Rs -0 Cr
Cost of goods sold (latest year)Rs 0 Cr
Total expenditure (latest year)Rs 9 Cr
Total income (latest year)Rs 0 Cr
Share capitalRs 23 Cr
ReservesRs -11 Cr
Shareholders' fundsRs 12 Cr
Total assetsRs 14 Cr
Capital work in progressRs 2 Cr
InvestmentsRs 10 Cr
ReceivablesRs 0 Cr
Other liabilitiesRs 1 Cr
Shares outstanding (crore)2.27
Ownership
Promoter holding25.44% (-22.81 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/B 2.28 is at the 2th percentile (median 5.30).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 539267 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -4.9% | -2.8% | -2.2 pts |
| 1 month | +8.8% | -6.8% | +15.6 pts |
| 3 months | -0.4% | -7.6% | +7.2 pts |
| 3 years | -27.7% | +14.2% | -41.8 pts |
| 5 years | -71.6% | +27.9% | -99.5 pts |
Red flags
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹0 Cr.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Dr Lal Pathlabs Ltd | 32,737 | 58.2 | 28.0 % |
| Vijaya Diagnostic Centre Ltd | 15,192 | 81.0 | 20.5 % |
| Metropolis Healthcare Ltd | 11,665 | 56.0 | 17.8 % |
| Thyrocare Technologies Ltd | 8,708 | 48.2 | 35.4 % |
| Nephrocare Health Services Ltd | 6,671 | 78.4 | 15.3 % |
| Suraksha Diagnostic Ltd | 1,847 | 51.6 | 17.3 % |
| Krsnaa Diagnostics Ltd | 1,791 | 18.1 | 12.7 % |
| 3B Blackbio DX Ltd | 1,396 | 25.1 | 25.5 % |
| One Global Service Provider Ltd | 1,046 | 14.1 | 87.0 % |
| Health X Platform Ltd | 923 | 0.03 % | |
| Gaudium IVF and Women Health Ltd | 830 | 35.9 | 29.3 % |
| Chandan Healthcare Ltd | 581 | 22.1 | 23.3 % |
| Pramodini Medicare Ltd | 259 | 14.9 | 41.8 % |
| Aspira Pathlab & Diagnostics Ltd | 148 | 2.84 % | |
| Choksi Laboratories Ltd | 132 | 69.2 | 9.44 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Samsrita Labs Ltd?
Samsrita Labs Ltd (539267) has a market capitalisation of Rs 26.8 Cr. at the 2026-10-01 close.
What were Samsrita Labs Ltd's latest quarterly results?
In the Jun 2026 quarter, Samsrita Labs Ltd sales was Rs 0 Cr with a net loss of Rs 0 Cr.